News

Unprecedented Canada-wide movement to improve pediatric cancer treatment

In Canada, cancer remains the leading cause of illness-related death in children. In an effort to accelerate research breakthroughs...

Research trainees, enter the CFI’s #IAmInnovation Twitter contest to win!

Calling all students and post-docs — between October 2 and December 1, 2017, the Canada Foundation for Innovation (CFI) wants to hear how working in state-of-the-art facilities and with cutting-edge equipment has helped you and...

Searching for the “signature” causes of BRCAness in breast cancer

Breast cancer cells with defects in the DNA damage repair–genes BRCA1 and BRCA2 have a mutational signature...

Joint Summer Student Research Day: A new part of the summer culture

For students eager to spend a few months in a leading research laboratory and conduct a hands-on project, summer is the time to try it...

Encouraging results for patients with aggressive brain cancer

Being diagnosed with a malignant brain tumor is devastating news for patients and their loved ones. Whereas some types...

Dr. Patricia Tonin receives the Karen Campbell Award for Research Excellence

Dr. Patricia Tonin, professor of the McGill University departments of Medicine and Human Genetics and associate leader of the Cancer Research Program of the Research Institute...

Dr. Morag Park awarded prestigious Robert L. Noble Prize

Dr. Morag Park, Professor of Biochemistry, Medicine and Oncology and Director of the Goodman Cancer Research Centre at McGill...

New marker and potential therapy for triple negative breast cancer

Triple negative breast cancer (TNBC) is the most aggressive type of breast cancer, found in 15-20% of all cases. These breast tumors are...

New marker identified for pancreatic cancer

Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related deaths. Due to its deep anatomical location, tumour-specific symptoms typically occur only...

A race against time to diagnose deadly weight loss in cancer patients

About one third of cancer patients die because of cachexia – an involuntary weight loss, characterized primarily by muscle wasting and metabolic changes, which cannot be addressed or treated solely...